Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry
European Respiratory Journal · 2023-12 · 62 (6) · 2300819
DOI: 10.1183/13993003.00819-2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 19.10.2023. Verfasst von P Jane McDowell und 16 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK. Hauptthemen laut MEDLINE: Asthma, Biological Products, Anti-Asthmatic Agents. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Novel biologic therapies have revolutionised the management of severe asthma with more ambitious treatment aims. Here we analyse the definition of clinical remission as a suggested treatment goal and consider the characteristics associated with clinical remission in a large, real-world severe asthma cohort.
Methods
This was a retrospective analysis of severe asthma patients registered in the UK Severe Asthma Registry (UKSAR) who met strict national access criteria for biologics. Patients had a pre-biologics baseline assessment and annual review. The primary definition of clinical remission applied included Asthma Control Questionnaire (ACQ)-5
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wellcome Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.
- Belfast Health and Social Care NHS Trust, Belfast, UK.
- Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK janemcdowell@doctors.org.uk.
- Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.
- Royal Brompton and Harefield Hospitals, London, UK.
- Guy's Severe Asthma Centre, Guy's Hospital, School of Immunology and Microbial Sciences, King's College London, London, UK.
ORCID-Profile: P Jane McDowell, James W Dodd
Zitieren
APA
McDowell, P. J., McDowell, R., Busby, J., Eastwood, M. C., Patel, P. H., Jackson, D. J., Mansur, A., Patel, M., Burhan, H., Doe, S., Chaudhuri, R., Gore, R., Dodd, J. W., Subramanian, D., Brown, T., Heaney, L. G., & UK Severe Asthma Registry (2023). Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry. European Respiratory Journal, 62(6), 2300819. https://doi.org/10.1183/13993003.00819-2023
Vancouver
McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, et al. Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry. European Respiratory Journal. 2023;62(6):2300819. doi:10.1183/13993003.00819-2023
BibTeX
@article{McDowell2023,
author = {McDowell, P Jane and McDowell, Ron and Busby, John and Eastwood, M Chad and Patel, Pujan H and Jackson, David J and Mansur, Adel and Patel, Mitesh and Burhan, Hassan and Doe, Simon and Chaudhuri, Rekha and Gore, Robin and Dodd, James W and Subramanian, Deepak and Brown, Thomas and Heaney, Liam G and UK Severe Asthma Registry, UK Severe Asthma Registry},
title = {Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry},
journal = {European Respiratory Journal},
year = {2023},
volume = {62},
number = {6},
pages = {2300819},
doi = {10.1183/13993003.00819-2023}
}
EUVIMED